Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00339976 · ClinicalTrials.gov registry record

Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis

A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).

Completed
Registry status

NCT00339976 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS).

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00339976 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).

COMPLETED
Registry status

Study Summary

This study is a follow-up to an earlier study that examined the relationship of This study will examine whether exposure to neurotoxins, such as lead, mercury, solvents, and pesticides, can contribute to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The cause of this degenerative disease of the brain and spinal cord is not well understood. Some studies suggest that exposure to environmental neurotoxins may increase its risk. This follow-up study will examine the relationship of neurotoxin exposure to the interval between the diagnosis of ALS and death. It will also examine the possible roles of genetics, lifestyle and dietary factors in the disease. Information on ALS patients previously enrolled in the study will be used to examine this relationship. No new individuals will be enrolled in the study.

Trial Details

FieldValue
Start Date 2002-08-06
Est. Completion 2008-04-21

What the Registry Record Tells You About NCT00339976

The ClinicalTrials.gov registry entry for NCT00339976 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute of Environmental Health Sciences (NIEHS), which has 145 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00339976 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00339976 about?

NCT00339976 is a clinical study titled "Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis". This study is a follow-up to an earlier study that examined the relationship of This study will examine whether exposure to neurotoxins, such as lead, mercury, solvents, and pesticides, can contribute to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The cause of this degen...

What is the current status of trial NCT00339976?

This trial is currently completed. The study started on 2002-08-06. Estimated completion is 2008-04-21.

Who is sponsoring clinical trial NCT00339976?

This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.